The plasma membrane Ca 2+ ATPase 2 (PMCA2) is necessary for auditory transduction and serves as the primary Ca 2+ extrusion mechanism in auditory stereocilia bundles. To date, studies examining PMCA2 in auditory function using mutant mice have focused on the phenotype of late adolescent and adult mice. Here, we focus on the changes of PMCA2 in the maturation of auditory sensitivity by comparing auditory responses to RNA and protein expression levels in haploinsufficient PMCA2 and wild-type mice from P16 into adulthood. Auditory sensitivity in wild-type mice improves between P16 and 3 weeks of age, when it becomes stable through adolescence. In haploinsufficient mice, there are frequency-dependent loss of sensitivity and subsequent recovery of thresholds between P16 and adulthood. RNA analysis demonstrates that α-Atp2b2 transcript levels increase in both wild-type and heterozygous cochleae between P16 and 5 weeks. The increases reported for the α-Atp2b2 transcript type during this stage in development support the requisite usage of this transcript for mature auditory transduction. PMCA2 expression also increases in wild-type cochleae between P16 and 5 weeks suggesting that this critical auditory protein may be involved in normal maturation of auditory sensitivity after the onset of hearing. We also characterize expression levels of two long noncoding RNA genes, Gm15082 (lnc82) and Gm15083 (lnc83), which are transcribed on the opposite strand in the 5′ region of Atp2b2 and propose that the lnc83 transcript may be involved in regulating α-Atp2b2 expression.
INTRODUCTION
Auditory transduction relies on the development of a complex set of cell types to transform the mechanical movements of the basilar membrane into an electrical signal that can be interpreted by the brain. The organ of Corti, the auditory sensory epithelium of the cochlea, is made of a range of stereotypically defined cell types including nonsensory cells and inner and outer hair cells as well as a variety of supporting cell types which include Deiters' cells, Hensen's cells, and pillar cells that maintain the structural morphology of the epithelium. In combination with the development of specialized cells in the sensory epithelium of the inner ear are corresponding changes in the expression of proteins and transcription factors that eventually determine the physiological function of a particular cell type (Kelley 2006) .
It has been well established that PMCA2 is required for auditory transduction in the mature mammalian cochlea (Kozel et al. 1998; Street et al. 1998; Yamoah et al. 1998; Dumont et al. 2001; McCullough and Tempel 2004) . PMCA2 is a neuronal PMCA isoform that is expressed in spiral ganglia neurons which innervate the hair cells of the inner ear, and is abundantly expressed in the stereocilia bundles of outer hair cells Dumont et al. 2001; Wood et al. 2004; Chen et al. 2012) . Coordinated auditory responses are not detected in mice until around P12 which is commonly denoted as the "onset of hearing" (Mikaelian and Ruben 1965) . Expression of PMCA2 mRNA is detected as early as P0 in the rodent cochlea, and strong expression persists in spiral ganglia and outer hair cells into adulthood (Furuta et al. 1998) . Concordantly, PMCA2 expression begins to appear at P0 in outer hair cells at the base of the cochlea, reaches the apex by P6, and expression along the tonotopic axis is maintained in stereocilia bundles through P21 (Chen et al. 2012) .
These studies suggest that PMCA2 expression is established before the onset of hearing and helps permit the initiation of auditory transduction. However, it is less clear if there are changes in PMCA2 mRNA and protein expression after the onset of hearing and into adulthood. We set out to determine if PMCA2 plays a role in the maturation of auditory transduction immediately after the onset of hearing. In this study, we assess auditory sensitivity and PMCA2 expression in both wild-type and reduced-PMCA2 expressing mice beginning at P16 and show that PMCA2 regulation is dynamic even after the onset of hearing.
METHODS

Animals
The reduced expression strain, +/dfw i5 (Watson and Tempel 2013), and wild-type littermates used in this study ranged in age from P16 to 9 weeks of age. All of the dfw i5 mice have been backcrossed into CBA/ CaJ (CBA) for 10-13 generations, designated as incipient congenic CBACa.D2(B6)-Atp2b2 dfwi5 . The original dfw i5 mouse was on a mixed DBA/2J (DBA) and C57BL6/J (B6) background, with the mutation on a DBA allele. Known hearing loss loci in B6 and DBA were crossed out of our dfw i5 line by N5. The +/dfw i5 mice and littermate controls used for expression analysis at P16 and P20 were time-mated and tested exactly 4 days apart to be as precise as possible at this early developmental stage. Tissue was collected from +/dfw i5 mice and wildtype littermates at P16, P20, and 5 weeks of age for Atp2b2 and PMCA2 expression analysis. P16 and P20 tissues were collected on the same day as ABR testing in these individuals. Tissue from mice tested at 5 weeks (P35-P38) was collected between P38 and P48, and for simplicity is referred to as "5-week" tissue, even if it was collected in the sixth post-natal week. Another haploinsufficient allele, Atp2b2 dfw2J , used in this study arose spontaneously in CBy.A/J-Ttc7 fsn at the Jackson Laboratory (JAX) and was obtained in 1997. The +/ dfw 2J mice have also been backcrossed into CBA and were from generations 18 to 20, designated as congenic strain CBACa.Cby-Atp2b2 dfw2J . Mice are maintained in a backcross to CBA which are obtained from JAX and replaced every three to four generations to retain a stock that is isogenic with CBA at JAX. Animals were kept on a 12-h light/dark cycle and kept in an environment with minimal exposure to noise. All procedures were approved by the University of Washington Institutional Animal Care and Use Committee.
Auditory Testing
All mice were tested for auditory sensitivity using auditory brainstem responses (ABRs) across frequencies ranging from 5.6 to 40 kHz. Mice were anesthetized with a mixture of ketamine (130 mg/kg) and xylazine (10 mg/kg) prior to auditory testing and put into a sound proof box on a heating pad and secured with a bite plate. The system was calibrated at the beginning of each day of testing to confirm the equipment was working properly and that the speaker output was within the normal range. To ensure consistency between recordings at early developmental ages, P16 and 3 weeks, the same calibration file was loaded for all ABR testing of these groups. A series of 350 tones at a given frequency and intensity were administered, and brain responses were recorded with two electrodes placed subcutaneously at the forebrain and hindbrain. A reference electrode was placed on the animal's hindlimb, and electrocardiogram recordings were monitored to ensure an appropriate level of anesthesia throughout the experiment. Tones were 3 ms long with a 1-ms rise/fall cos 2 function (delivered with alternating polarity). Brain waves were recorded for 15 ms following the initiation of each tone with 75 ms spacing between repetitions (13.3 Hz). ABRs are amplified (1,000×) and filtered (0.3-3 kHz) by a pre-amplifier (P55; Grass Telefactor, West Warwick, RI) and digitized. Threshold at a particular frequency was determined by visual detection as the lowest intensity sound (dB SPL) which evoked a recognizable and reproducible brain wave (at least two out of three trials), usually wave V.
Real-Time PCR
For RNA expression analysis, fresh brain stem or cochlear tissue was stored in RNAlater (Qiagen), equilibrated for 24 h at 4°C to allow the solution to penetrate the tissue, and transferred to −20°C for later use. After perfusion of the cochleae with RNAlater, the vestibular portion of the inner ear was removed in cochlear dissections in addition to the removal of as much bone, vasculature, debris, and neuronal tissue as possible. The protocols for RNA isolation, primers, and procedures for qPCR were the same as described previously (Watson and Tempel 2013) . Copy numbers for each transcript of interest were normalized to those of reference genes, Actb (β-actin) and Sdha (succinate dehydrogenase, subunit A). Additional primer sets used to quantify specific Atp2b2 transcript types, noncoding RNA genes, and Atp2b4 are as follows: α-Atp2b2, 5′-CGGAGTGTGGACTG ACAGCA-3′ and 5′-GGTTACATCAGAGGCGCCAG-3′; β-Atp2b2, 5′-GCTGGCGATTGCCTTAGC-3′ and 5′-GAGGAGTGTCCCCAGGAGTG-3′; Gm15082, 5′-CAG GCAATGGTAGTTACCCTGTA-3′ and 5′-GAAAG CCACTCAGGGAAGTG-3′; Gm15083, 5′-CTCATGC TCCTGCTGTGAAG-3′ and 5′-GGTTCACCAACT CCCTGAAG-3′; and Atp2b4, 5′-TCCCAGTGGCTG
Cochlear Westerns
The Western blotting protocol and buffers were the same as previously described (Watson and Tempel 2013) with a few changes. Whole cochlear samples were dissected on ice in Western lysis buffer by quickly removing both cochleae from the temporal bone. Lysis buffer was quickly perfused through the oval window, and cochleae were trimmed of as much excess bone, debris, vasculature, and neuronal tissue as possible while keeping the whole cochlea intact. In particular, the semi-circular canals were removed, and vestibular epithelia cleared leaving only tissue past the round and oval windows. Both cochleae from one mouse (constituting n = 1) were pooled together into a sterile microtube containing 90 μl lysis buffer and stored at −80°C until further use. Cochleae were homogenized directly in the microtube with a new, sterile pestle (Argos Technologies), and protein concentrations of each sample were determined using a BCA assay (Pierce). Aliquots containing 10 μg of each sample were mixed with sample buffer, denatured for 10 min at 50°C, cooled, and then loaded directly onto a 4-20 % polyacrilamide RGEL (BioRad) or stored at −20°C for later use. Primary antibody concentrations were 1:50,000 for β-actin (monoclonal mouse, Sigma) and 1:2,000 for PMCA2 (N-terminal, polyclonal rabbit, Affinity BioReagents). Secondary antibody concentrations were 1:70,000 (anti-mouse IgG from sheep, GE Life Sciences) and 1:2,000 (anti-rabbit IgG from donkey, GE Life Sciences), respectively. The ECL Prime kit (GE Healthcare) was used to generate the chemiluminescent signal which was visualized immediately using a Fotodyne Luminary/FX instrument (Fotodyne Inc.). Two blots containing all individuals of both ages (P16 and 5 weeks, with half of each age on each blot) of a particular genotype were run in parallel, transferred in parallel, and incubated in the same antibody solutions to directly compare PMCA2 expression differences by age. This process was performed at least twice for each sample, so each data point reflects at minimum a duplicate for each sample. PMCA2 expression in each lane was normalized to β-actin expression. A 10-μg cochlear standard was also loaded onto each gel to allow us to standardize replicates between blots and approximate the relative level of expression between genotypes. The images published in this manuscript have been inverted to look like a conventional blot, and have not been manipulated in any other way. Quantification was done on the longest exposure for each set of paired blots where none of the pixels were saturated.
RESULTS
Maturation of Auditory Sensitivity in Normal and PMCA2 Mutant Mice
To assess how PMCA2 contributes to the maturation of auditory sensitivity after the onset of hearing, ABR thresholds of wild-type and PMCA2 mutant mice were compared. Mice lacking PMCA2 are completely deaf so the haploinsufficient strain, +/dfw i5 (Watson and Tempel 2013), was used to determine the effect of a reduction of PMCA2 expression on auditory development. Mice begin to hear around post-natal day 12 (P12) and have a mature endocochlear potential by P14 (Mikaelian and Ruben 1965) . To ensure consistently detectable auditory brainstem responses, thresholds were assessed first at P16, followed by 3 (P20 or P21), 4, 5, 7, and 9 weeks of age (Fig. 1A ). Statistical differences between +/dfw i5 and wild-type controls are indicated in each panel, and threshold differences between notable ages within a group are described in Table 1 . While wildtype thresholds improved at nearly all frequencies between P16 and 3 weeks, thresholds in +/dfw i5 stayed the same (5.6, 8, and 11.3 kHz) or were noticeably worse (16 kHz and above) at this stage in auditory development. Thus, 3 weeks of age marks a critical time point in the development of auditory transduction in wild-type and +/dfw i5 mice, with overall sensitivity improving in one group and worsening in the other. Variability of +/ dfw i5 thresholds (Fig. 1B) suggests that sensitivity changes rapidly around 3 weeks of age in the mid-frequencies. Wild-type thresholds were unchanged after 3 weeks of age at each frequency tested. In +/dfw i5 , thresholds at 5.6 kHz never matured from P16 into adulthood suggesting that reduced PMCA2 expression can nega-tively impact low-frequency hearing. Thresholds recovered at 11.3 and 16 kHz to wild-type levels by 4 weeks of age and partially improved at 22.6 kHz, but not at 32 or 40 kHz. Loss (and subsequent recovery) of sensitivity seen at 3 weeks of age in mice heterozygous for another PMCA2 null allele, dfw 2J , demonstrates this is not a unique feature of +/dfw i5 ( Fig. 2) . Therefore, the mature auditory phenotype of haploinsufficient PMCA2 mice relies on frequency-dependent recovery of sensitivity between 3 and 4 weeks of age.
Atp2b2 Regulation After the Onset of Hearing
Improvements in wild-type auditory thresholds at the same age when thresholds worsen in +/dfw i5 suggest there exists a minimal required level of PMCA2 expression for normal auditory development. To see if Atp2b2 (the gene that encodes PMCA2) regulation changes during this critical period, we quantified total Atp2b2 mRNA as well as specific expression of neuronal transcript types, α-and β-Atp2b2 (Silverstein and Tempel 2006). Expression levels were quantified using whole cochlear RNA preps from individual mice at P16, P20, and 5 weeks of age (Fig. 3) . These three time points should adequately capture a snapshot of expression levels before, during, and after the critical 3-week time point. The main cell types contributing to Atp2b2 expression in the prep are auditory hair cells and spiral ganglion neurons. Spiral ganglia express both α-and β-Atp2b2 transcript types while auditory i5 expression of each transcript type was approximately half (~60 %) of wild-type expression (overall effect of genotype in a two-way ANOVA, PG0.0001 for all transcript types, F 1,28 =169.0 for total Atp2b2, F 1,28 = 121.9 for α-Atp2b2, and F 1,28 =163.3 for β-Atp2b2). Total transcript expression in both groups trends upwards between P16 and 5 weeks of age (Fig. 3A) and is statistically increased in +/dfw i5 (overall effect of age in a two-way ANOVA, F 2,28 =5.492, P=0.0097 and t 12 = 2.448, PG0.05 in a Bonferroni post hoc comparison). The α-Atp2b2 transcript approximately doubled in both wild-type and +/dfw i5 mice between P16 and 5 weeks, which was statistically higher than levels at both P16 and P20 for each group (overall effect of age in a two-way ANOVA, F 2,28 =74.29, PG0.0001) (Fig. 3B) . In contrast, expression of β-Atp2b2 did not change in the cochlea during this time frame (Fig. 3C) . The increase in α-Atp2b2, but not β-Atp2b2, in the cochlea of both wild-type and +/dfw i5 mice suggests that the α-Atp2b2 transcript type is particularly important for auditory transduction.
To account for transcriptional or compensatory differences in +/dfw i5 , α-and β-Atp2b2 expression levels in each +/dfw i5 individual were normalized to the wildtype expression level for that transcript type and then compared (Fig. 3D) . Preferential usage of α-Atp2b2 over β-Atp2b2 was seen at 5 weeks of age (t 8 =4.501, P=0.0020 in a paired, two-way t test), but not at P16 or P20, suggesting a compensatory change in Atp2b2 regulation occurs after 3 weeks of age in +/dfw i5 mice. To determine whether the increase in α-Atp2b2 expression is a global change or if it is unique to the cochlea, brain stem samples from each group and age were also assessed for total, α-and β-Atp2b2 expression (Fig. 4) . Unlike the cochlea, total, α-and β-Atp2b2 levels in the brain stem were relatively stable over this time frame in both groups (Fig. 4A-C) with no overall effect of age in a two-way ANOVA for total and β-Atp2b2. There was an overall effect of age in a two-way ANOVA for α-Atp2b2 (F 2,34 =6.086, P=0.0055) caused by a small increase in expression of wild-type transcript at P20 (t 9 =3.331, PG0.01 between P16 and P20 and t 11 =2.773, PG0.05 between P20 and 5 weeks in a Bonferroni post hoc comparison). As in Fig. 3D , compensatory changes in +/dfw i5 were assessed by normalizing brain stem α-Atp2b2 and β-Atp2b2 expression for each +/dfw i5 individual to wild-type expression for each transcript (Fig. 4D) . In the brain stem tissue of +/dfw i5 individuals, there was again a small, but significant, preference for α-over β-Atp2b2 transcript usage at 5 weeks of age when normalized to wild-type expression (t 8 =2.750, P=0.025 in a paired, two-way t test). To examine if increased α-Atp2b2 expression in the cochlea results in an increase in PMCA2, protein levels in whole cochlea of wild-type and +/dfw i5 mice at P16 and 5 weeks of age were assessed via Western blotting (Fig. 5A) . Wild-type PMCA2 expression increased in the cochlea between P16 and 5 weeks (Fig. 5B , open circles, t 11 =5.519, P=0.0002 in an unpaired, two-tailed t test). However, in +/dfw i5 , despite an increase in α-Atp2b2 transcript, cochlear PMCA2 expression did not increase above P16 levels (Fig. 5B , gray squares, t 11 =0.2850, P=0.7809 in an unpaired, two-tailed t test). These data suggest that an increase in cochlear PMCA2 expression may contribute to the maturation of auditory sensitivity after P16 in normal auditory development. Likewise, 
FIG. 2. Auditory development in +/
FIG. 3. Cochlear α-Atp2b2 is upregulated by 5 weeks of age. A
Total Atp2b2 expression increases in cochlea of +/dfw i5 mice between P16 and 5 weeks of age. B-C Levels of α-Atp2b2, but not β-Atp2b2, increase for both wild-type and heterozygous mice throughout auditory development in the cochlea. *PG0.05, **PG 0.01, and ***PG0.001 in a Bonferroni post hoc test following a twoway ANOVA (panels A-C). D Relative expression of α-Atp2b2 and β-Atp2b2 is shown for individual +/dfw i5 mice at each age in the cochlea. Expression levels for both transcripts were normalized to the average wild-type transcript expression at each age. Preferential upregulation of α-Atp2b2 is apparent in the cochlea of +/dfw i5 at unchanged PMCA2 expression in +/dfw i5 may contribute to the worsening of auditory sensitivity after P16 in these mice.
Noncoding RNAs may be Involved in Atp2b2 Regulation
Our RNA data suggested that, in both groups of mice, regulation of α-Atp2b2 seemed to be particularly important during the developmental stage between P16 and 5 weeks of age. In wild-type mice, the increase in α-Atp2b2 transcript was more indicative of the change in PMCA2 expression than were total or β-Atp2b2 transcript levels. In +/dfw i5 , although PMCA2 expression did not increase in the cochlea, the preferential increase in α-Atp2b2 transcript over β-Atp2b2 suggests an attempt to compensate for a lack of PMCA2 expression by upregulation of α-Atp2b2. We asked whether nearby genomic elements might regulate α-Atp2b2 during auditory development. The Atp2b2 gene is over 300 kb long with several large intronic regions. It has become increasingly apparent that intronic and intergenic regions of the genome can serve important regulatory and functional roles in mammalian organisms (Consortium EP 2012). We noticed that two uncharacterized noncoding RNA genes, Gm15082 (lnc82) and Gm15083 (lnc83), sit complementary to the 5′ end of Atp2b2 (Fig. 6A) . Expression of these RNAs was confirmed in the brain stem and cochlea of 5-week-old wild-type mice (Fig. 6B, C) . The lnc82 RNA is primarily expressed in the brain stem with minimal expression in the cochlea, and lnc83 RNA is primarily expressed in the cochlea with negligible expression in the brain stem (Fig. 6B) . Abundance relative to total Atp2b2 expression is also shown for each lncRNA and tissue type (Fig. 6C ).
Both lncRNA transcripts were then quantified from the same cDNAs of both wild-type and +/dfw i5 mice used to measure Atp2b2 expression at P16, P20, and 5 weeks of age (Fig. 7) . Expression levels of lnc82 and lnc83 in the brain stem, as well as lnc82 in the cochlea, are stable over this time course. Conversely, lnc83 expression is markedly higher at P16 in the cochlea of both wild-type (CBA) and +/dfw i5 mice. Levels decrease at P20 in each genotype, and are lowest at 5 weeks of age. We cannot help but notice that downregulation of lnc83 seems to coincide with the upregulation of α-Atp2b2 (compared to Fig. 4B ) and that Gm15083 (the gene encoding lnc83) spans the transcriptional start site and proximal promoter for α-Atp2b2 (see Fig. 6A ). The lnc83 transcript is also highly expressed in the cochlea (compared to the brain stem) where α-Atp2b2 is the predominant transcript type. Taken together, these results suggest that lnc83 RNA might be involved in regulating α-Atp2b2 expression and tissue specificity. Further functional studies will be required to confirm these hypotheses.
PMCA4 Does Not Compensate for Loss of PMCA2 in +/dfw i5
While our data suggest that changes in Atp2b2 and PMCA2 expression may contribute to the maturation of auditory sensitivity in wild-type and +/dfw i5 mice, there are likely changes in expression levels of other genes between P16 and 5 weeks of age. We postulated that, in +/dfw i5 , other genes expressed during early auditory development might remain at higher levels to compensate for the reduction in PMCA2 expression. Furthermore, such a gene might account for the recovery of sensitivity after 3 weeks of age in these mice. Other calcium handling mechanisms, especially in neuronal tissue, may help compensate for the increased calcium load. The mRNA for another calcium ATPase, PMCA4, which is encoded by the Atp2b4 gene, is expressed at its highest levels in the developing cochlea at P12 (Furuta et al. 1998 ) and is aberrantly expressed in the stereocilia of adult null-PMCA2 mice (Wood et al. 2004) . For these reasons, we considered PMCA4 as a candidate for compensation in +/dfw i5 . Quantification of cochlear cDNAs show a reduction of Atp2b4 expression in both wild-type and +/dfw i5 mice by 5 weeks of age (overall effect of age in a two-way ANOVA, F 3,28 =53.91, PG0.0001) (Fig. 8) , indicating its expression continues to decrease even after the onset of hearing in mice. As there were no expression differences between wild-type and +/dfw i5 groups, it appears that PMCA4 does not compensate for reduced PMCA2 function in adult +/dfw i5 mice.
DISCUSSION
Here, we examine the effect of PMCA2 on auditory maturation and show that this critical hearing protein is also important for the proper development of auditory function. Recently, the appearance of PMCA2 in rat stereocilia bundles was characterized and found to be expressed first at the base in P0 animals and at the apex by P6 (Chen et al. 2012 ). This finding, paired with the appearance of cochlear Atp2b2 mRNA before the onset of hearing (Furuta et al. 1998) , suggests that PMCA2 expression is established before coordinated auditory transduction begins. Our findings demonstrate that PMCA2 expression continues to change even after the onset of hearing and that an increase in cochlear PMCA2 may be a component of the auditory maturation process. We also find that a reduction of PMCA2 alters the course of auditory maturation during the third post-natal week in mice.
Expression of Atp2b2 and PMCA2 is Dynamic After the Onset of Hearing
We report a specific elevation in α-Atp2b2 expression in the cochlea occurring after the onset of hearing in both wildtype and +/dfw i5 mice. This increase in α-Atp2b2 transcript correlates to an increase in cochlear PMCA2 expression by 5 weeks of age in wild-type mice, but does not appear to influence protein expression in +/dfw i5 mice. While it is unclear why PMCA2 expression does not also increase in +/dfw i5 , there appears to be a compensatory change in the transcriptional regulation of the α-Atp2b2 and β-Atp2b2 transcript types between P16 and 5 weeks of age in both cochlear and brain stem tissue of these mice. It is possible that a change in α-Atp2b2 regulation in +/dfw i5 contributes to the partial recovery of auditory sensitivity by 5 weeks of . A Western blots of cochlear tissue from +/dfw i5 and wild-type littermates at each age were assessed for PMCA2 expression (see "Methods"). Representative examples of blots from wild-type (top) and +/dfw i5 (bottom) mice that were used to compare PMCA2 expression at P16 and 5 weeks of age within a genotype. On average, the four cochlear samples from individual P16 wild-type mice have reduced PMCA2 band intensity compared to three 5-week wild-type mice. Conversely, there is no noticeable difference between cochlear PMCA2 band intensity in three +/dfw i5 mice at P16 and four +/dfw i5 mice at 5 weeks of age. B PMCA2 expression was normalized to β-actin band intensity (arbitrary units) and quantified from sets of paired blots run with a standard to compare expression within pairs and estimate the relative expression between genotypes. The blots shown in panel "A" represent one blot each from a paired set of each genotype. There is approximately a 50 % increase in cochlear PMCA2 expression between P16 and 5 weeks in wild-type mice. Cochlear PMCA2 expression does not increase by 5 weeks in +/dfw i5 , which likely contributes to abnormal maturation of auditory sensitivity in these animals.
FIG. 6.
Two lncRNA genes sit complementary to Atp2b2 and are expressed in the brain stem and cochlea of wild-type mice. A The schematic shows the location of the 5′ region of α-Atp2b2 (black exons) on the antisense strand of Chr. 6. The Atp2b2 gene is transcribed from the reverse strand while two predicted long noncoding RNA genes (open or closed teal exons) sit complementary to the 5′ region of Atp2b2 on the forward strand of Chr. 6. Gm15083 (or lnc83) spans the α-Atp2b2 transcriptional start, and Gm15082 (lnc82) sits between the second and third untranslated exons of the α-Atp2b2 transcript. The β-Atp2b2 transcriptional start and translational start exons are also shown for reference. Exon sizes and relative positions on Chr. 6 are to scale. B-C LncRNA genes are expressed in a tissue-specific manner in wild-type mice with lnc82 expression predominating in the brain stem and lnc83 expression predominating in the cochlea. Graphs represent absolute expression levels (B) and abundance relative to total Atp2b2 expression in wildtype mice (C). Error bars represent SEM.
FIG. 7.
Lnc83 is downregulated in the cochlea by 5 weeks of age.
Levels of lnc82 and lnc83 were quantified in the brain stem and cochlea of wild-type and +/dfw i5 mice during auditory development. Expression of lnc82 and lnc83 in the brain stem, as well as lnc82 in the cochlea, does not change over this time frame, and there are no grouped differences between wild-type and heterozygous littermates. For both wild-type and +/dfw i5 , lnc83 expression in the cochlea is significantly downregulated between P16, P20, and 5 weeks of age. ***PG0.001 in a Bonferroni post hoc comparison following a two-way ANOVA. Error bars represent SEM.
age in this strain, although it is also likely that compensatory changes in other calcium handling mechanisms in hair cell stereocilia (Lumpkin and Hudspeth 1998) may also occur. Unchanged PMCA2 expression in +/dfw i5 cochleae, however, is consistent with the altered development of auditory sensitivity in these mice and suggests a role for PMCA2 in auditory maturation.
We also characterize the expression levels of two long noncoding RNA gene transcripts, lnc82 and lnc83, that sit on the opposite strand of the 5′ region of the Atp2b2 gene. The lnc83 expression is oppositely correlated with α-Atp2b2 expression in the cochlea of both wild-type and +/dfw i5 mice. The transcriptional start site of α-Atp2b2 sits in the intronic region of the lnc83 gene suggesting that lnc83 might interfere specifically with α-Atp2b2 transcription via indirect or direct mechanisms. Recently, examples of long noncoding RNAs acting as transcriptional repressors support this view (Huarte et al. 2010; Wang and Chang 2011; Maamar et al. 2013) . The genomic proximity and expression patterns of the Atp2b2 and Gm15083 genes and their resulting transcripts implicate lnc83 as a potential regulator of α-Atp2b2 expression and tissue specificity. We expect that further studies on the mechanism of lnc83 and other long noncoding RNAs in the mouse auditory system will reveal more detailed regulatory roles.
PMCA2 as a Component of Auditory Maturation
Consistent with other reports, auditory sensitivity of wild-type mice improves between P16 and 3 weeks of age (Mikaelian and Ruben 1965; Song et al. 2006) . However, two reduced PMCA2 expression strains, +/dfw i5 and +/dfw 2J , demonstrate a distinct loss of auditory sensitivity at 3 weeks of age with frequency-dependent recovery by 5 weeks of age. Worsening of thresholds between P16 and 3 weeks may be attributed, in part, to the presence of PMCA1 mRNA in outer hair cells at P16 which disappears by P21 (Furuta et al. 1998 since Atp2b4 transcript is expressed at equivalent levels in the cochlea of these mice as in wild-type controls, suggesting that another mechanism for compensation occurs in these mice. It is also possible that the amount of PMCA2 expressed in these strains at P16 is adequate for this stage in development, but that by 3 weeks of age, this level is no longer sufficient for normal auditory transduction. The third post-natal week is a critical period in auditory refinement and maturation of altricial mammals. Many features of both the central and peripheral auditory systems become "adult-like" during this time and include maturation of the endocochlear potential (Woolf et al. 1986 ; Sadanaga and Morimitsu 1995) changes in cochlear morphology and mechanics (Kraus and Aulbach-Kraus 1981; Mills and Rubel 1996; Overstreet et al. 2002; Emadi and Richter 2008; Song et al. 2008) as well as reorganization and refinement of tonotopicity (Echteler et al. 1989; Muller 1996; Yu et al. 2007) .
A closer examination at each of the frequencies tested in Fig. 1 lends insight into the mechanism for PMCA2-related hearing loss in mice. At 5.6 and 8 kHz, ABR thresholds do not change dramatically after P16, neither worsening at 3 weeks nor improving thereafter. Why thresholds never improve at 5.6 kHz is a matter of speculation, but indicates that loss of sensitivity at these lowest frequencies in a PMCA2 mutant might be attributed to a different mechanism than hearing loss at higher frequencies in the same animals. Nonetheless, loss at 5.6 kHz suggests the necessity of PMCA2 for normal low-frequency hearing. That thresholds in +/+ and +/dfw i5 at 8 kHz are virtually identical throughout development suggests this frequency is the most resistant to PMCA2 dysfunction and might represent the tonotopic location where there is a switch between low-and highfrequency mechanisms for hearing loss. Thresholds at 11.3 kHz are indistinguishable from controls at every age but the critical 3 week time point where maturation of thresholds lags by 1 week.
At frequencies at and above 16 kHz, the degree of hearing loss at 3 weeks of age is at least 35- 1977; Prosen et al. 1978; Stebbins et al. 1979 ) and indicates that, at these frequencies, +/dfw i5 does not provide enough PMCA2 activity at 3 weeks to fully support the signal amplification function attributed to outer hair cells (Brownell et al. 1985; Evans and Dallos 1993) . At 16 and 22.6 kHz, +/dfw i5 animals are able to fully or partially recover sensitivity throughout adolescence, respectively. These frequencies seem to represent the tonotopic location where transduction is sensitive, and yet the most receptive, to a reduction in PMCA2 expression and compensatory changes, respectively.
Finally, at 32 and 40 kHz, +/dfw i5 mice maintain the 40-45 dB shift in sensitivity through 9 weeks of age. It is characteristic at these high frequencies to have a significant hearing loss due to a reduction in PMCA2 function (McCullough and Tempel 2004) . Recent work suggests that high-frequency hair cells in PMCA2 mutants may be the most susceptible to calcium overload and subsequent death (Spiden et al. 2008; Bortolozzi et al. 2010; Watson and Tempel 2013) because they have an equivalent density of PMCA2 molecules as lowfrequency hair cells (Chen et al. 2012 ) despite having larger MET channel conductances (Ricci et al. 2003; Beurg et al. 2006) . These data support the idea that a mechanism involving Ca 2+ homeostasis contributes to loss at these frequencies and that compensatory changes occurring after 3 weeks in +/ dfw i5 cannot augment function in these high-frequency hair cells.
The relatively dramatic differences in sensitivity across the tonotopic axis of the mouse cochlea during this developmental stage suggest that Ca 2+ clearance (and therefore cytosolic Ca 2+ concentration) is a critical determinant of hair cell function, with a concomitant narrow window for PMCA2 function. Furthermore, we propose that Ca 2+ handling mechanisms continue to mature in the mouse cochlea well after the onset of hearing as evidenced by the dynamic changes in Atp2b2 and PMCA2 expression between P16 and 5 weeks of age.
